Suppr超能文献

监测诊断为脓毒症或发热性中性粒细胞减少症的儿科肿瘤患者的血液学参数:一家三级中心的经验

Monitoring Hematologic Parameters in Pediatric Oncology Patients Diagnosed With Sepsis or Febrile Neutropenia: A Tertiary Center Experience.

作者信息

Radulescu Florin-Mihai, Nedea Ilie Marina Ionela, Dumitru Irina-Magdalena

机构信息

Medicine, Doctoral School of Medicine, Ovidius University of Constanta, Constanta, ROU.

Pediatrician, "Marie Sklodowska Curie" Emergency Clinical Hospital for Children, Bucharest, ROU.

出版信息

Cureus. 2025 Jun 20;17(6):e86413. doi: 10.7759/cureus.86413. eCollection 2025 Jun.

Abstract

This study analyzes hematologic and inflammatory parameters in pediatric oncology patients with febrile neutropenia (FN) or sepsis, aiming to identify simple diagnostic markers. Conducted in a tertiary center, 150 infectious episodes were evaluated. Results showed statistically significant differences in leukocyte (G1: 4.95-7.03, p=0.01/G2: 4.91-7.01, p=0.01) and neutrophil counts (G1: 3.10-4.05, p=003/G2: 3.22-5.70, p=0.02) after treatment, especially in sepsis cases, with a statistically significant decrease in C-reactive protein (p=0.01) and procalcitonin (p=0.01) post-therapy. Although fibrinogen showed limited diagnostic value, the observed variation may still reflect a relevant pattern, as suggested in prior research. These findings highlight the importance of accessible biomarkers in guiding early diagnosis and management in resource-limited healthcare settings.

摘要

本研究分析了患有发热性中性粒细胞减少症(FN)或脓毒症的儿科肿瘤患者的血液学和炎症参数,旨在确定简单的诊断标志物。在一家三级中心进行了研究,评估了150次感染发作。结果显示,治疗后白细胞(G1:4.95 - 7.03,p = 0.01/G2:4.91 - 7.01,p = 0.01)和中性粒细胞计数(G1:3.10 - 4.05,p = 0.03/G2:3.22 - 5.70,p = 0.02)有统计学上的显著差异,尤其是在脓毒症病例中,治疗后C反应蛋白(p = 0.01)和降钙素原(p = 0.01)有统计学上的显著下降。尽管纤维蛋白原显示出有限的诊断价值,但观察到的变化仍可能反映出一种相关模式,正如先前研究所表明的那样。这些发现突出了可获取的生物标志物在资源有限的医疗环境中指导早期诊断和管理的重要性。

相似文献

3
Infection Biomarkers in Children with Chemotherapy-Induced Severe Neutropenia.
Cancers (Basel). 2025 Jul 2;17(13):2227. doi: 10.3390/cancers17132227.
4
Very early discharge versus early discharge versus non-early discharge in children with cancer and febrile neutropenia.
Cochrane Database Syst Rev. 2016 Feb 22;2(2):CD008382. doi: 10.1002/14651858.CD008382.pub2.
6
8
CD177, MYBL2, and RRM2 Are Potential Biomarkers for Musculoskeletal Infections.
Clin Orthop Relat Res. 2025 Jun 1;483(6):1062-1071. doi: 10.1097/CORR.0000000000003402. Epub 2025 Feb 6.

本文引用的文献

1
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations.
Nat Cancer. 2023 Feb;4(2):203-221. doi: 10.1038/s43018-022-00474-y. Epub 2022 Dec 30.
3
Neutropenia and Infection Prophylaxis in Childhood Cancer.
Curr Oncol Rep. 2022 Jun;24(6):671-686. doi: 10.1007/s11912-022-01192-5. Epub 2022 Mar 1.
4
Prognostic Communication Between Oncologists and Parents of Children With Advanced Cancer.
Pediatrics. 2021 Jun;147(6). doi: 10.1542/peds.2020-044503. Epub 2021 May 5.
6
Rethinking Success in Pediatric Oncology: Beyond 5-Year Survival.
J Clin Oncol. 2021 Jul 10;39(20):2227-2231. doi: 10.1200/JCO.20.03681. Epub 2021 Mar 26.
7
Global effect of the COVID-19 pandemic on paediatric cancer care: a cross-sectional study.
Lancet Child Adolesc Health. 2021 May;5(5):332-340. doi: 10.1016/S2352-4642(21)00031-6. Epub 2021 Mar 4.
8
Cancer Statistics, 2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
9
Childhood cancer: Survival, treatment modalities, late effects and improvements over time.
Cancer Epidemiol. 2021 Apr;71(Pt B):101733. doi: 10.1016/j.canep.2020.101733. Epub 2020 May 24.
10
Febrile neutropenia in paediatric oncology.
Paediatr Child Health (Oxford). 2020 Mar;30(3):93-97. doi: 10.1016/j.paed.2019.12.002. Epub 2020 Jan 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验